Dr. Patrick Fleming, MD

Dr. Fleming practices at Princeton Medical Center in Plainsboro, New Jersey, part of University of Pennsylvania.

Dr. Fleming's NPI, 1538615794, was assigned on August 28, 2016. Dr. Fleming holds Pennsylvania license 25MA10612200.

Dr. Fleming's primary practice is Princeton Medical Center, at One-Five Plainsboro Road, Plainsboro, NJ 08536 in Middlesex County. The practice phone is (609) 853-6500. Dr. Fleming also practices at Princeton Medical Center, 1 Plainsboro Rd, Plainsboro, NJ 08536.

Dr. Fleming's primary practice is Princeton Medical Center in Plainsboro, New Jersey, part of University of Pennsylvania. Dr. Fleming is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Fleming to 2 more hospitals, 4 group practices and clinics, 4 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleming practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Fleming's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Fleming is licensed in Pennsylvania.

CMS data shows 1,088 Medicare services from Dr. Fleming across 9 procedure codes in 2024, for 229 Medicare patients. Medicare paid $71,277 for them.

CMS counts 229 Medicare patients who saw Dr. Fleming in 2024. The largest group is 75 to 84, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fleming's median patient age at 68, with 57% women.

In 2024, Dr. Fleming wrote 269 Medicare Part D claims for 62 patients. 75% of them were for generic drugs. CMS names the drug for 106 of them, across 6 drugs with 11 or more claims each, at $18,884 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

Dr. Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fleming as offering telehealth.

CMS Open Payments shows 5 general payments to Dr. Fleming from 3 drug and device companies from 2022 to 2024. Education make up the largest share, 78% of the total. Abbvie Inc. paid the most, $116.